IMMUTEP LIMITED — Capital/Financing Update 2007

Nov 21, 2007

==> picture [193 x 52] intentionally omitted <==

ABN 90 009 237 889

22 November 2007

ASX ANNOUNCEMENT NOTICE UNDER SECTION 708A(5) OF THE CORPORATIONS ACT

[ASX Code: PRR]

This notice is given under paragraph (5)(e) of section 708A of the Corporations Act.

The following securities of Prima BioMed Limited (“the Company”) were issued without disclosure to investors under Part 6D.2 of the Corporations Act:

Type:	Shares
Class/Description:	Ordinary (fully paid)
ASX Code:	PRR
Date of Issue:	22November 2007
Number Issued:	15,170,970
Issue Price per Security	$0.02

The Company intends to apply to ASX Limited for quotation of the above securities.

As at the date of this notice, the Company has complied with:

• (a) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

• (b) section 674 of the Corporations Act.

Other information which is excluded information required to be disclosed under paragraph (6)(e) of section 708A of the Corporations Act:

None

For and on behalf of Prima BioMed Limited

==> picture [172 x 73] intentionally omitted <==

Robert Kleine

Company Secretary

Prima BioMed Limited , Suite 1, 1233 High Street, Armadale, VIC 3143 AUSTRALIA Ph: +61 (0)3 9854 5700 Fax: +61 (0)3 9822 7735 www.primabiomed.com.au